Clinical study on the treatment of allergic rhinitis with Chinese herbal medicine desensitization Zhixiao Decoction: a randomized controlled trial

Shanghai Dongfang Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•Inclusion criteria
•All the following conditions should be met for the included patients:
•(1) Those who met the diagnostic criteria of moderate to severe persistent allergic rhinitis;
•(2) According to the international diagnostic criteria (ARIA) of AR:
•? Clinical symptoms: two or more symptoms such as sneezing, clear water like runny nose, nasal itching and nasal congestion, lasting or accumulating for more than 1 hour every day;
•? Allergen test: at least one allergen SPT and / or serum specific IgE were positive.
•(3) The TNSS score should be = 4.
•(4) They were 18-65 years old;
•(5) Informed consent, signed informed consent form, and volunteers.

•Exclusion criteria
•Those with one of the following conditions will be excluded from this study:
•(1) Patients with acute sinusitis or respiratory tract infection in the past two weeks;
•(2) Patients with bronchial asthma, moderate or above atopic dermatitis, immune diseases and severe chronic inflammatory diseases;
•(3) History of drug allergy;
•(4) Those who have received specific immunotherapy in the past two years, and those who have received anti allergic Chinese medicine, systemic hormone therapy or antihistamine therapy in the past two weeks;
•(5) Pregnant or lactating patients.
•(6) Severe lung, liver, kidney disease or other serious primary disease.

发起方

Shanghai Dongfang Hospital